Javier Arranz
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Clinical Impact and Prognostic Value of Alzheimer Disease Biomarkers in the Very Old.
Journal: Neurology
Published: June 17, 2026
Evidence for bilingualism as a cognitive reserve factor in biomarker-confirmed Alzheimer's disease.
Journal: medRxiv : the preprint server for health sciences
Published: April 10, 2026
Bilingualism's protective effects in Alzheimer's disease: Mechanisms of resilience and resistance.
Journal: medRxiv : the preprint server for health sciences
Published: February 27, 2026
Bilingualism's protective effects in Alzheimer's disease: Mechanisms of resilience and resistance.
Journal: medRxiv : the preprint server for health sciences
Published: February 27, 2026
CSF and plasma tau biomarkers in the Down syndrome-Alzheimer's disease continuum.
Journal: EBioMedicine
Published: January 22, 2026
Peak width of skeletonized mean diffusivity reveals early and multifactorial white matter injury across sporadic and Down syndrome-associated Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: January 20, 2026
Characterizing circadian rest-activity rhythm patterns across Alzheimer's disease continuum in Down syndrome.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: January 08, 2026
The predictive power of neuropsychological measures in MCI: early detection of dementia conversion.
Journal: Frontiers in aging neuroscience
Published: November 05, 2025
Natural history and clinical impact of epilepsy in adults with Down syndrome: a multicentre clinical study.
Journal: Lancet (London, England)
Published: October 31, 2025
Temporal dynamics of white matter hyperintensities related to Alzheimer's disease in adults with Down syndrome.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: October 22, 2025
Factors impacting survival in individuals with Down syndrome-associated Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: October 09, 2025
Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapies.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: September 11, 2025
Last Updated: 09/26/2026